KALA BIO shares surge 11.13% intraday after settling $10.6 million in debt, improving liquidity and investor confidence.

KALA BIO, Inc. (KALA) surged 11.13% intraday trading following the announcement that it settled approximately $10.6 million of debt, reducing its financial obligations and signaling improved liquidity. The company also closed a $10 million registered direct offering of common stock, further strengthening its balance sheet and providing capital for operational flexibility. These developments likely bolstered investor confidence, driving the sharp intraday rally.